Preformed enzymes in mast cell granules and their potential role in allergic rhinitis

Current Allergy and Asthma Reports

Volumn 3, Issue 3, 2003, Pages 266-272

  Parikh, Smruti A ^a   Cho, Seong H ^a   Oh, Chad K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ARACHIDONIC ACID DERIVATIVE; BRADYKININ; CELL ENZYME; CORTICOSTEROID; CYTOKINE; DNA VACCINE; ETANERCEPT; HEPARIN; HISTAMINE; HISTAMINE H1 RECEPTOR AGONIST; INFLIXIMAB; INTERLEUKIN 4 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; N (1 HYDROXY 2 NAPHTHOYL)ARGINYLPROLINAMIDE; OLIGODEOXYNUCLEOTIDE; OMALIZUMAB; RECEPTOR BLOCKING AGENT; ROFLUMILAST; TRYPTASE; TRYPTASE INHIBITOR; UNCLASSIFIED DRUG; ARACHIDONIC ACID; CHYMASE; INTERLEUKIN DERIVATIVE; SERINE PROTEINASE;

ALLERGIC DISEASE; ALLERGIC RHINITIS; B LYMPHOCYTE; CELL FUNCTION; CELL GRANULE; CYTOKINE RELEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG MEGADOSE; DRUG METABOLISM; FIRST PASS EFFECT; GENE THERAPY; HUMAN; IMMUNOTHERAPY; LEUKOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MAST CELL; MEDIATOR RELEASE; REVIEW; SIDE EFFECT; SYMPTOM; T LYMPHOCYTE; ANIMAL; ENZYMOLOGY; HAY FEVER; METABOLISM; PERENNIAL RHINITIS; PHYSIOLOGY;

ANIMALS; ARACHIDONIC ACID; CHYMASES; CYTOPLASMIC GRANULES; HISTAMINE; HUMANS; INTERLEUKINS; MAST CELLS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0037645139     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-003-0049-y     Document Type: Review

References (43)

1. Mekori YA, Metcalfe DD: Mast cell-T cell interactions. J Allergy Clin Immunol 1999, 104:517-523.
2. Grutzkau A, Kruger-Krasagakes S, Baumeister H, et al.: Synthesis, storage and release of vascular endothelial growth factor/ vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 1998, 9:875-884.
3. Kendall JC, Li XH, Galli SJ, Gordon JR: Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor α and transforming growth factor b. J allergy Clin Immunol 1997, 99:113-123.
4. Lindstedt KA, Kokkonen JO, Kovanen PT: Regulation of the activity of secreted human lung mast cell tryptase by mast cell proteoglycans. Biochim Biophys Acta 1998, 1425:617-627.
5. Schneider E, Rolli-Derkinderen M, Arock M, Dy M: Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 2002, 23:255-263.
6. Bachert C: The role of histamine in allergic disease: reappraisal of its inflammatory potential. Allergy 2002, 57:287-296.
7. Okamoto Y, Shirotori K, Kudo K, et al.: Cytokine expression after topical administration of substance P to human nasal mucosa: the role of substance P in nasal allergy. J Immunol 1993, 151:4391-4398.
8. Farber HW, Weller PF, Rounds S, et al.: Generation of lipid neutrophils chemoattractant activity by histamine-stimulated cultured endothelial cells. J Immunol 1986, 137:2918-2924.
9. Asako H, Kurose I, Wolf R, et al.: Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in post-capillary venules. J Clin Invest 1994, 93:1508-1515.
10. Temkin V, Kantor B, Weg V, et al.: Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol 2002, 169:2662-2669.
11. Imamura T, Dubin A, Moore W, et al.: Induction of vascular permeability enhancement by tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest 1996, 74:861-870.
12. Cairns JA, Walls AF: Mast cell tryptase stimulates the synthesis of type I collagen in human fibroblasts. J Clin Invest 1997, 99:1313-1321.
13. Cairns JA, Walls AF: Mast cell tryptase is a mitogen for epithelial cells: stimulation of IL-8 production and ICAM expression. J Immunol 1996, 156:275-283.
14. Thabrew H, Cairns JA, Walls AF: Mast cell tryptase is a growth factor for human airway smooth muscle cells [abstract]. J Allergy Clin Immunol 1996, 97:969.
15. Sommerhof CP, Caughey GH, Finkbeiner WE, et al.: Mast cell chymase: a potent secretagogue for airway gland serous cells. J Immunol 1989, 142:2450-2456.
16. Sage H, Woodbury RC, Bornstein P: Structural studies on human type IV collagen. J Exp Med 1979, 254:9893-9900.
17. Proud D, Macglashan DW Jr, Newhall HH, et al.: Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. Am Rev Respir Dis 1985, 132:405-408.
18. Proud D, Reynolds CJ, Lacapra S, et al.: Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis 1988, 137:613-616.
19. Walsh LJ, Trinchieri G, Waldorf HA, et al.: Human dermal mast cells contain and release tumor necrosis factor which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 1991, 88:4220-4224.
20. Leibovich SJ, Polverini PJ, Shepard HM, et al.: Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature 1987, 329:630-632.
21. Gorgon JR, Galli SJ: Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the FcεRI: role for mast cell-derived transforming growth factor b and tumor necrosis factor a. J Exp Med 1994, 180:2027-2037.
22. Sanico AM, Stanisz A, Gleeson TD, et al.: Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am J Respir Crit Care Med 2000, 161:1631-1635.
23. Bradding P: Human mast cell cytokines. Clin Exp Allergy 1996, 26:13-19.
24. Matsuoka T, Hirata M, Tanaka H, et al.: Prostaglandin D2 as a mediator of allergic asthma. Science 2000, 287:2013-2016.
25. Tedeschi A, Palumbo G, Milazzo N, et al.: Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor. J Allergy Clin Immunol 1994, 93:526-533.
26. Allen DB: Systemic effects of intranasal steroids: an endocrinologist's perspective. J Allergy Clin Immunol 2000, 106:S179-S190.
27. Nayak AS, Philip G, Lu S: Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol 2002, 88:592-600.
28. Plewako H, Arvidsson M, Petruson K, et al.: The effect of omalizumab on nasal allergic inflammation. J Allergy Clin Immunol 2002, 110:68-71.
29. Adelroth E; Rak S, Haahtela T, et al.: Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000, 106:253-259.
30. Clark JM, Abraham WM, Fishman CE, et al.: Tryptase inhibitors block allergen-induced airway and inflammatory responses in allergic sheep. Am J Respir Crit Care Med 1995, 152:2076-2083.
31. Krishna MT, Chauhan A, Little L: Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. J Allergy Clin Immunol 2001, 107:1039-1045.
32. Weston MC, Peachell PT: Regulation of human mast cell and basophil function by cAMP. Gen Pharmacol 1998, 31:715-719.
33. Schmidt BX4: The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis. J Allergy Clin Immunol 2001, 108:530-536.
34. Knight DM, Trinh H, Le J, et al.: Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 1993, 30:1443-1453.
35. Moreland LW, Baumgartner SW, Schiff MH, et al.: Treatment of rheumatoid arthritis with recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997, 337:141-147.
36. Baram D, Rashkovsky M, Hershkoviz R: Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast-cell dependent cutaneous inflammation. Clin Exp Immunol 1997, 110:485-491.
37. Vancheri C, Mastruzzo C, Armato F, et al.: Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis. J Allergy Clin Immunol 2001, 108:703-708.
38. Durham SR, Walker SM, Varga, EM, et al.: Long term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999, 341:468-475.
39. Sur S, Wild JS, Choudhary B, et al.: Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999, 162:6284-6293.
40. Hsu CH, Chua KY, Tao MH: Inhibition of specific IgE response in vivo by allergen-gene therapy. Int Immunol 1996, 8:1405-1411.
41. Roy K, Hai-Quan M, Huang S, et al.: Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999, 5:387-391.
42. Karras JG, McGraw K, McKay RA, et al.: Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse model of asthma. J Immunol 2000, 164:5409-5415.
43. Metzger WJ, Nyce JW: Oligonucleotide therapy of allergic asthma. J Allergy Clin Immunol 1999, 104:260-266.